Sanofi’s tolebrutinib fails primary endpoint in multiple sclerosis trial
Welcome to World Breaking News, your trusted source for fast, accurate, and impactful news coverage from around the globe. We are a dedicated team of journalists, editors, and news enthusiasts committed to delivering breaking stories, in-depth analysis, and real-time updates on politics, business, technology, sports, entertainment, and more.
© Copyright -World Breaking News -2025